Keyphrases
Omomyc
100%
Mouse Model
41%
MYC Inhibition
36%
Tumor Cells
35%
C-Myc Inhibitor
32%
Miniprotein
29%
Oncogene
26%
Dominant Negative
22%
Cell-penetrating
21%
Patient-derived Xenograft
21%
Estrogen Receptor
20%
Tumor
20%
Tumor Suppressor
20%
Human Cancer
19%
Clinical Applicability
17%
Non-small Cell Lung Cancer (NSCLC)
17%
Tumorigenesis
16%
Lung Cancer
15%
Human Tumors
14%
In Cancer
14%
Fusion Systems
14%
Undruggable
14%
Intrinsically Disordered
14%
Oncoprotein
14%
Hormone Binding
12%
Ligand-binding Domain
12%
Splice Isoforms
11%
Leucine Zipper
11%
Melanoma
11%
Metastatic Breast Cancer
11%
Prognostic Signature
11%
Cancer Heterogeneity
11%
Cancer Precision Medicine
11%
Pancreatic Duct Cells
11%
4-OHT
11%
Non-small Cell Lung Cancer Cells
11%
SMARCB1
11%
Tumor Growth in Vivo
11%
Cell Self-renewal
11%
Atypical Teratoid Rhabdoid Tumor (AT/RT)
11%
Functional Inclusion Bodies
11%
Reversible Switching
11%
Breast Cancer Progression
11%
Wnt Signaling
11%
Signaling Receptor
11%
Pancreatic Islets
11%
Biophysical Characterization
11%
Helix
11%
Family Protein
11%
Tumor Protein p53 (TP53)
11%
Biochemistry, Genetics and Molecular Biology
Myc
71%
Mouse Model
44%
Tumor Progression
37%
Transgenics
26%
Estrogen Receptor
23%
Carcinogenesis
22%
Clinical Trial
21%
Tumor Suppressor Protein
20%
Hormone Binding
15%
Binding Domain
15%
Experimental Model
14%
Cancer Cell
14%
Leucine Zipper
13%
Pharmacokinetics
11%
Metastasis Inhibition
11%
Antineoplastic Activity
11%
CD44
11%
Evolution
11%
Isoform
11%
Stromal Cell
11%
Gene Signature
11%
Cell Self-Renewal
11%
Oncogene C Myc
11%
Therapeutic Protein
11%
Wnt Signaling Pathway
11%
Dynamics
11%
KRAS
11%
SMARCB1
11%
Chimeric Protein
11%
Ligand Binding
11%
Genetics
10%
DNA Binding
10%
Oncogene
10%
Drug Targeting
8%
Dimerization
8%
Cell Culture
8%
Gene Expression
7%
High Throughput Sequencing
5%
Serum (Blood)
5%
Cell Culture Technique
5%
Immunity
5%
Cell Transformation
5%
Coculture
5%
Mass Spectrometry
5%
Mitogen-Activated Protein Kinase
5%
Gemcitabine
5%
Medicine and Dentistry
Malignant Neoplasm
80%
Neoplasm
38%
Side Effect
24%
In Vitro
24%
Tumor Progression
24%
Xenograft
19%
Carcinogenesis
18%
Tumor Cell
17%
Cancer Therapy
15%
Oncogene
14%
Medicine
13%
Breast Cancer
11%
Ganglioglioma
11%
Rhabdoid Tumor
11%
Cell Self-Renewal
11%
Atypical Teratoid Rhabdoid Tumor
11%
Personalized Medicine
11%
Cancer Cell
11%
Nuclear Protein
11%
Receptor
11%
Wnt Signaling
11%
Pancreatic Islet
11%
Antisense
11%
Melanoma
11%
Translational Medicine
11%
Clinical Trial
11%
Cell Culture
6%
Ligand Binding
5%
Chronic Disease
5%
Protein-Protein Interaction
5%
Non Small Cell Lung Cancer
5%
Therapy Effect
5%
Stromal Cell
5%
Mouse Model of Cancer
5%
Binding Site
5%
Phosphorus 31
5%
Systemic Administration
5%
Nesidioblastosis
5%
Expression Regulation
5%
Pharmacophore
5%
Protein-DNA Interaction
5%
Gene Expression
5%
